Nasdaq · Common stock
CG Oncology (CGON)
$61.56 −$0.15 (−0.24%)
- Day’s range
- $61.06–$62.80
- Volume
- 880,160
CGON price history
CGON closed at $61.56 on Oct. 26, 2026. Over the past year, its daily close ranged from $37.37 on Dec. 17, 2025 to $80.68 on Aug. 19, 2026.
Data table: CGON daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $61.56 |
| Oct. 23, 2026 | $61.71 |
| Oct. 22, 2026 | $62.54 |
| Oct. 21, 2026 | $62.24 |
| Oct. 20, 2026 | $61.93 |
| Oct. 19, 2026 | $59.96 |
| Oct. 16, 2026 | $59.85 |
| Oct. 15, 2026 | $61.86 |
| Oct. 14, 2026 | $61.84 |
| Oct. 13, 2026 | $62.40 |
| Oct. 12, 2026 | $63.13 |
| Oct. 9, 2026 | $63.82 |
| Oct. 8, 2026 | $63.26 |
| Oct. 7, 2026 | $62.38 |
| Oct. 6, 2026 | $63.64 |
| Oct. 5, 2026 | $68.71 |
| Oct. 2, 2026 | $67.38 |
| Oct. 1, 2026 | $68.35 |
| Sept. 30, 2026 | $70.89 |
| Sept. 29, 2026 | $70.52 |
| Sept. 28, 2026 | $69.61 |
| Sept. 25, 2026 | $67.15 |
| Sept. 24, 2026 | $68.76 |
| Sept. 23, 2026 | $73.36 |
| Sept. 22, 2026 | $77.74 |
| Sept. 21, 2026 | $78.25 |
| Sept. 18, 2026 | $74.62 |
| Sept. 17, 2026 | $75.62 |
| Sept. 16, 2026 | $74.12 |
| Sept. 15, 2026 | $72.55 |
| Sept. 14, 2026 | $73.79 |
| Sept. 11, 2026 | $72.35 |
| Sept. 10, 2026 | $72.00 |
| Sept. 9, 2026 | $71.96 |
| Sept. 8, 2026 | $73.40 |
| Sept. 4, 2026 | $74.67 |
| Sept. 3, 2026 | $74.33 |
| Sept. 2, 2026 | $74.59 |
| Sept. 1, 2026 | $75.86 |
| Aug. 31, 2026 | $75.16 |
| Aug. 28, 2026 | $74.34 |
| Aug. 27, 2026 | $79.01 |
| Aug. 26, 2026 | $78.42 |
| Aug. 25, 2026 | $78.95 |
| Aug. 24, 2026 | $78.23 |
| Aug. 21, 2026 | $79.81 |
| Aug. 20, 2026 | $77.61 |
| Aug. 19, 2026 | $80.68 |
| Aug. 18, 2026 | $76.29 |
| Aug. 17, 2026 | $77.11 |
| Aug. 14, 2026 | $75.03 |
| Aug. 13, 2026 | $74.71 |
| Aug. 12, 2026 | $76.99 |
| Aug. 11, 2026 | $77.03 |
| Aug. 10, 2026 | $76.56 |
| Aug. 7, 2026 | $75.10 |
| Aug. 6, 2026 | $74.85 |
| Aug. 5, 2026 | $72.42 |
| Aug. 4, 2026 | $71.40 |
| Aug. 3, 2026 | $69.15 |
| July 31, 2026 | $71.19 |
| July 30, 2026 | $73.03 |
| July 29, 2026 | $69.12 |
| July 28, 2026 | $72.62 |
| July 27, 2026 | $73.52 |
| July 24, 2026 | $69.32 |
| July 23, 2026 | $71.12 |
| July 22, 2026 | $69.31 |
| July 21, 2026 | $71.72 |
| July 20, 2026 | $70.19 |
| July 17, 2026 | $71.85 |
| July 16, 2026 | $69.50 |
| July 15, 2026 | $73.00 |
| July 14, 2026 | $71.77 |
| July 13, 2026 | $72.50 |
| July 10, 2026 | $75.24 |
| July 9, 2026 | $73.32 |
| July 8, 2026 | $69.80 |
| July 7, 2026 | $69.20 |
| July 6, 2026 | $69.26 |
| July 2, 2026 | $70.36 |
| July 1, 2026 | $70.89 |
| June 30, 2026 | $71.05 |
| June 29, 2026 | $73.73 |
| June 26, 2026 | $71.96 |
| June 25, 2026 | $72.84 |
| June 24, 2026 | $68.72 |
| June 23, 2026 | $65.73 |
| June 22, 2026 | $66.25 |
| June 18, 2026 | $61.08 |
| June 17, 2026 | $60.43 |
| June 16, 2026 | $60.28 |
| June 15, 2026 | $59.55 |
| June 12, 2026 | $59.56 |
| June 11, 2026 | $57.64 |
| June 10, 2026 | $54.92 |
| June 9, 2026 | $56.67 |
| June 8, 2026 | $54.40 |
| June 5, 2026 | $53.72 |
| June 4, 2026 | $56.09 |
| June 3, 2026 | $54.42 |
| June 2, 2026 | $55.53 |
| June 1, 2026 | $59.23 |
| May 29, 2026 | $62.29 |
| May 28, 2026 | $60.73 |
| May 27, 2026 | $60.80 |
| May 26, 2026 | $61.89 |
| May 22, 2026 | $64.25 |
| May 21, 2026 | $64.59 |
| May 20, 2026 | $64.76 |
| May 19, 2026 | $63.30 |
| May 18, 2026 | $62.93 |
| May 15, 2026 | $66.93 |
| May 14, 2026 | $69.54 |
| May 13, 2026 | $74.00 |
| May 12, 2026 | $72.07 |
| May 11, 2026 | $69.32 |
| May 8, 2026 | $69.62 |
| May 7, 2026 | $69.18 |
| May 6, 2026 | $68.01 |
| May 5, 2026 | $67.18 |
| May 4, 2026 | $67.70 |
| May 1, 2026 | $66.27 |
| April 30, 2026 | $66.74 |
| April 29, 2026 | $64.75 |
| April 28, 2026 | $65.55 |
| April 27, 2026 | $66.82 |
| April 24, 2026 | $68.68 |
| April 23, 2026 | $69.89 |
| April 22, 2026 | $69.88 |
| April 21, 2026 | $71.84 |
| April 20, 2026 | $70.40 |
| April 17, 2026 | $73.43 |
| April 16, 2026 | $66.34 |
| April 15, 2026 | $67.68 |
| April 14, 2026 | $67.28 |
| April 13, 2026 | $67.70 |
| April 10, 2026 | $67.70 |
| April 9, 2026 | $68.56 |
| April 8, 2026 | $68.87 |
| April 7, 2026 | $69.81 |
| April 6, 2026 | $67.55 |
| April 2, 2026 | $67.48 |
| April 1, 2026 | $66.79 |
| March 31, 2026 | $67.68 |
| March 30, 2026 | $63.96 |
| March 27, 2026 | $64.62 |
| March 26, 2026 | $66.67 |
| March 25, 2026 | $65.81 |
| March 24, 2026 | $63.84 |
| March 23, 2026 | $64.96 |
| March 20, 2026 | $65.08 |
| March 19, 2026 | $65.86 |
| March 18, 2026 | $64.45 |
| March 17, 2026 | $68.64 |
| March 16, 2026 | $65.90 |
| March 13, 2026 | $64.29 |
| March 12, 2026 | $62.97 |
| March 11, 2026 | $64.66 |
| March 10, 2026 | $62.80 |
| March 9, 2026 | $61.29 |
| March 6, 2026 | $61.88 |
| March 5, 2026 | $60.37 |
| March 4, 2026 | $61.57 |
| March 3, 2026 | $60.55 |
| March 2, 2026 | $57.76 |
| Feb. 27, 2026 | $58.80 |
| Feb. 26, 2026 | $56.11 |
| Feb. 25, 2026 | $56.99 |
| Feb. 24, 2026 | $58.34 |
| Feb. 23, 2026 | $58.31 |
| Feb. 20, 2026 | $57.63 |
| Feb. 19, 2026 | $56.42 |
| Feb. 18, 2026 | $55.21 |
| Feb. 17, 2026 | $53.87 |
| Feb. 13, 2026 | $51.50 |
| Feb. 12, 2026 | $51.62 |
| Feb. 11, 2026 | $53.55 |
| Feb. 10, 2026 | $53.09 |
| Feb. 9, 2026 | $51.08 |
| Feb. 6, 2026 | $50.36 |
| Feb. 5, 2026 | $49.20 |
| Feb. 4, 2026 | $51.98 |
| Feb. 3, 2026 | $52.56 |
| Feb. 2, 2026 | $54.34 |
| Jan. 30, 2026 | $52.05 |
| Jan. 29, 2026 | $53.42 |
| Jan. 28, 2026 | $53.84 |
| Jan. 27, 2026 | $55.10 |
| Jan. 26, 2026 | $53.30 |
| Jan. 23, 2026 | $53.81 |
| Jan. 22, 2026 | $55.85 |
| Jan. 21, 2026 | $57.13 |
| Jan. 20, 2026 | $54.69 |
| Jan. 16, 2026 | $54.73 |
| Jan. 15, 2026 | $53.07 |
| Jan. 14, 2026 | $55.51 |
| Jan. 13, 2026 | $52.58 |
| Jan. 12, 2026 | $53.72 |
| Jan. 9, 2026 | $54.20 |
| Jan. 8, 2026 | $41.93 |
| Jan. 7, 2026 | $42.45 |
| Jan. 6, 2026 | $40.37 |
| Jan. 5, 2026 | $40.04 |
| Jan. 2, 2026 | $41.79 |
| Dec. 31, 2025 | $41.52 |
| Dec. 30, 2025 | $40.17 |
| Dec. 29, 2025 | $39.86 |
| Dec. 26, 2025 | $39.84 |
| Dec. 24, 2025 | $40.14 |
| Dec. 23, 2025 | $40.05 |
| Dec. 22, 2025 | $40.08 |
| Dec. 19, 2025 | $39.03 |
| Dec. 18, 2025 | $38.00 |
| Dec. 17, 2025 | $37.37 |
| Dec. 16, 2025 | $37.85 |
| Dec. 15, 2025 | $39.75 |
| Dec. 12, 2025 | $40.94 |
| Dec. 11, 2025 | $41.61 |
| Dec. 10, 2025 | $41.74 |
| Dec. 9, 2025 | $41.74 |
| Dec. 8, 2025 | $42.80 |
| Dec. 5, 2025 | $43.30 |
| Dec. 4, 2025 | $44.73 |
| Dec. 3, 2025 | $42.61 |
| Dec. 2, 2025 | $41.37 |
| Dec. 1, 2025 | $43.25 |
| Nov. 28, 2025 | $44.84 |
| Nov. 26, 2025 | $44.84 |
| Nov. 25, 2025 | $45.51 |
| Nov. 24, 2025 | $43.56 |
| Nov. 21, 2025 | $42.44 |
| Nov. 20, 2025 | $40.71 |
| Nov. 19, 2025 | $42.60 |
| Nov. 18, 2025 | $42.55 |
| Nov. 17, 2025 | $41.25 |
| Nov. 14, 2025 | $41.01 |
| Nov. 13, 2025 | $37.76 |
| Nov. 12, 2025 | $39.41 |
| Nov. 11, 2025 | $38.84 |
| Nov. 10, 2025 | $40.22 |
| Nov. 7, 2025 | $39.68 |
| Nov. 6, 2025 | $39.69 |
| Nov. 5, 2025 | $37.96 |
| Nov. 4, 2025 | $39.07 |
| Nov. 3, 2025 | $41.90 |
| Oct. 31, 2025 | $43.27 |
| Oct. 30, 2025 | $42.47 |
| Oct. 29, 2025 | $42.98 |
| Oct. 28, 2025 | $43.71 |
| Oct. 27, 2025 | $44.29 |
Key figures
- 52-week range
- $37.37–$80.68Low Dec. 17, 2025; high Aug. 19, 2026
- Average daily volume
- 869,201Past 3 months
- Market value
- $5.46B
- Dividend yield
- —
- From 52-week high
- −23.70%
Price change
- 1 month
- −8.32%
- 3 months
- −11.19%
- Year to date
- +48.27%
- 1 year
- +40.97%
$1,000 a year ago
$1,000 put into CGON at the close on Oct. 24, 2025 would be worth $1,410.
Price only, dividends not included.
What Wall Street says about CGON
In the past 90 days, Wall Street firms published 3 rating or price-target actions on CGON: 2 raised price targets and 1 lowered price target.
| Action | Rating | |||
|---|---|---|---|---|
| Piper Sandler | Raises target | Overweight | $82 to $85 | |
| RBC Capital | Cuts target | Outperform | $81 to $79 | |
| Truist Securities | Raises target | Buy | $82 to $85 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About CG Oncology, Inc. Common stock
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
- Headquarters
- Dallas, Texas
- Employees
- 142
- Listed
- Jan. 25, 2024
- Sector
- Health care
- Industry
- Biological products, (no diagnostic substances)
In WallStreetDigest editions
No WallStreetDigest article about CGON is on the site yet.